N/A N=93 Comparing 6-Minute Walk Tests for Ambulatory Oxygen Assessment
Respiratory Disease
Primary: Average Drop in SpO2 From Baseline to Nadir — 6; 5 SpO2 (%) — p=<0.01
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 1 N=10 Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
Graft Vs Host Disease · Graft-versus-host-disease
Primary: Safety and Tolerability of Belimumab as Prophylaxis of Chronic GvHD in Subjects Following alloHCT as Measured by Number of Participants Who Experience Each Adverse Event…
N/A N=60 Telehealth Delivery (Tele-B6)
HIV Seropositivity · Bisexuality
Primary: Acceptability Scale — 4.63; 4.68; 4.60; 4.70 score on a scale
N/A N=174 Evaluation of the Predictive Nature of the Postoperative CRP on Postoperative Recovery in Patients Undergoing Colorectal Resection (CRP-Track)
Colorectal Postoperative Complication
Primary: C-reactive Protein Rate — 47.9; 81.0; 50.0; 79.5 percentage
N/A N=225 A Pragmatic Trial of Brief CBT for Anxiety in VA Primary Care
Anxiety
Primary: General Anxiety Disorder-7 (GAD-7) — 15.4; 14.7; 11.6; 12.0 score on a scale
N/A N=513 Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
Primary: 28 Day Mortality in Pediatric ARDS. — 44 Participants — p=<0.05
Phase 3 N=243 A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.
COVID-19
Primary: Number of Participants With Improvement in at Least Two Categories in WHO 8-point Ordinal Clinical Scale at Day 28 or Discharge — 106; 104 Participants — p=0.1513
N/A N=8 AR Projections for Eye-gaze Evaluation in Phantoms
Kidney Stones
Primary: Stone Count — 80; 92 percentage
Phase 1 N=16 A Study in Healthy People to Test How BI 425809 is Taken up in the Body When Taken With or Without Food
Healthy
Primary: Area Under the Concentration-time Curve of BI 425809 in Plasma Over the Time Interval From 0 to the Last Quantifiable Data Point (AUC0-tz) — 4026.21; 4614.38…
Phase 4 N=42 ED90 for Hyperbaric Bupivacaine in Super Obese Parturients
Obesity, Morbid · Spinal Anesthesia · Cesarean Delivery
Primary: Number of Participants With Successful Blocks for Induction (Success Induction) — 1; 3; 27; 11 Participants
N/A N=13 Internet-based Cognitive-behavioral Treatment for Insomnia in COPD Patients Undergoing Pulmonary Rehabilitation
Chronic Obstructive Pulmonary Disease · Insomnia
Primary: Insomnia Severity Index (ISI) — -2.67; 0.40 score on a scale — p=0.121
N/A N=9 Mindfulness-based Cognitive Therapy for the Chronic Pain-early Cognitive Decline Co-morbidity Among Older Black Individuals in the Community; The Feeling of Being Open Pilot
Chronic Pain · Early Cognitive Decline
Primary: The Credibility and Expectancy Questionnaire — 35.07 Total Score
N/A N=127 Drivers of Suicide Mobile App Study
Suicide · Suicide, Attempted · Suicidal Ideation
Primary: Change in Self-Injurious Thoughts and Behaviors Interview-Revised — 0.92; 1.05; 0.62; 0.74 Scores on a scale
Phase 3 N=905 Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults
COVID-19 · SARS-CoV-2 Infection
Primary: Serum Immunoglobulin G (IgG) Antibody Levels to the SARS-CoV-2 Spike Protein Expressed as Geometric Mean ELISA Unit [GMEUs] — 34294.3; 36142.6; 33233.4; 91945.8 Elisa…
Phase 2 N=600 Long-Term Safety Study of Tafenoquine
Healthy Volunteers
Primary: Serious Ophthalmic Safety Event — 45; 48 Participants